Phase I/II Study of Gemcitabine and Docetaxel in Combination for Unresectable or Metastatic Pancreatic Cancer – GI98-1

Abstracts/Posters/Presentations:

• Bryan P Schneider, Kristen N Ganjoo, Lawrence H Einhorn, Joel Picus, Farid Fata, Patrick J Loehrer, Cindy Stoner. Phase II study of gemcitabine and docetaxel in combination for advanced pancreatic cancer: Hoosier Oncology Group GI98-1. Accepted as a poster presentation with discussion for ASCO annual meeting May 18-21, 2002, Orlando, FL.

Manuscripts/Articles:

• Ganjoo Kristen N., Gordon Michael S., Sandler Alan B., Warner Ruth E., Fife Karen, Poirier Shelley, Seshadri Roopa, Loehrer Patrick J. A Phase I Study of Weekly Gemcitabine and Docetaxel in Patients with Advanced Cancer: A Hoosier Oncology Group Study GI98-1. Oncology 2002;62:299-304. See abstract.